Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NanoKTN Facilitates Partnership between Bio Nano Consulting and The School of Pharmacy, University of London

Abstract:
Service level agreement increases industry exposure to academic experts to boost innovation in nanotechnology and biotechnology.

NanoKTN Facilitates Partnership between Bio Nano Consulting and The School of Pharmacy, University of London

UK | Posted on August 11th, 2010

The NanoKTN is pleased to announce the signing of a service level agreement (SLA) between two of its members, introduced by the NanoKTN at its Nano4Life event in February 2009. The SLA between industry-academia partnership specialist Bio Nano Consulting (BNC) and The School of Pharmacy, University of London, enables BNC to provide its clients with access to an increased pool of academic experts skilled in the fields of pharmaceutics, pharmacology and drug discovery.

The NanoKTN's primary aim is to encourage collaboration and knowledge transfer between key players in industry, as well as start-ups and SMEs. One of the key methods to ensure networking between key market players is to facilitate interactions through event organisation. By doing this, the NanoKTN supports the UK supply chain and creates economic wealth for UK industry.

Acknowledging the key role played by the NanoKTN in helping to bring about the research collaboration, Dr David Sarphie, CEO of BNC commented, "The NanoKTN plays an invaluable role in facilitating interaction between academia and industry, and, indeed, it was at the 2009 Nano4Life meeting, hosted by the NanoKTN, that BNC first recognised the potential of The School of Pharmacy's unique formulation technology and the benefits it provides for hard-to-deliver biotechnology drugs. We look forward to continuing to support the excellent work of the NanoKTN and utilising its expertise in future collaborative ventures."

The partnership has already enabled BNC to secure a contract with an undisclosed US-based biotechnology company. Under the terms of the agreement, BNC will manage a specific project carried out by scientists at The School of Pharmacy, to formulate a phase I cancer drug with the goal of making the treatment orally available, rather than delivered intravenously. Once a successful proof of concept is achieved, The School of Pharmacy will work with the company to take it to late-stage development.

Dr Sarphie remarked, "The SLA significantly expands our established pool of world class scientists that we manage and draw upon for specific life science projects, including cancer research. Indeed, the pace with which we have already secured the first contract with a biotechology company to apply the IP on offer at The School of Pharmacy, is testament to the standing in which The School of Pharmacy is held and the strength of the formulation technology that has been developed."

####

For more information, please click here

Copyright © NanoKTN

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Academic/Education

Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016

The University of Applied Sciences in Upper Austria uses Deben tensile stages as an integral part of their computed tomography research and testing facility October 18th, 2016

Enterprise In Space Partners with Sketchfab and 3D Hubs for NewSpace Education October 13th, 2016

New Agricultural Research Center Debuts at UCF October 12th, 2016

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Announcements

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotechnology

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Making spintronic neurons sing in unison November 18th, 2016

Research partnerships

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Quantum obstacle course changes material from superconductor to insulator December 1st, 2016

Novel silicon etching technique crafts 3-D gradient refractive index micro-optics November 28th, 2016

Single photon converter -- a key component of quantum internet November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project